Abstract
The study of peptide transport across the blood-brain barrier (BBB) is a field fraught with conflicting interpretations. This review presents a fairly strong case that peptides can be differentially transported at the BBB. However, minimal transport of peptides could have important impact on central nervous system (CNS) functions since only small amounts are needed for physiologic, pharmacologic and/or pathologic effects. Several BBB peptide transport mechanisms (i.e., receptor-mediated, absorptive-mediated, carrier-mediated and non-specific passive diffusion), as well as non-transport processes (i.e., endocytosis without transcytosis, aborption and metabolism) are discussed. It is emphasized that peptide transport systems at the BBB could be important targets for both therapeutic delivery of peptides and the development of certain brain pathologies. Strategies to manipulate peptide BBB transport processes have been discussed including lipidization, chemical modifications of the N-terminal end, coupling of transport with post-BBB metabolism and formation of potent neuroactive peptides, up-regulation of putative peptide transporters, use of chimeric peptides in which non-transportable peptide is chemically linked to a transportable peptide, use of monoclonal antibodies against peptide receptors, and binding of circulating peptides to apolipoproteins. It is suggested that future directions should be directed towards development of molecular strategies to up-regulate specific BBB peptide transporters to enhance brain delivery of peptide neuropharmaceuticals, or to down-regulate transport of peptides with potential role in cerebral pathogenesis.
Similar content being viewed by others
REFERENCES
J.G. McComb and B. V. Zlokovic. Cerebrospinal fluid and the blood-brain interface. In W. R. Cheek, A. E. Marlin, D. G. McLone, D. H. Reigel, and M. L. Walker (eds), Pediatric Neurosurgery, W. B. Saunders Co., Philadelphia, 1994, pp. 167–185.
P. A. Cancilla, J. Bready, and J. Berliner. Brain endothelial-astrocyte interactions. In W. M. Pardridge (eds), The Blood-Brain Barrier, Cellular and Molecular Biology, Raven Press, New York, 1993, pp. 25–46.
I. M. Herman. Microvascular pericytes in development and disease. In W. M. Pardridge (eds), The Blood-Brain Barrier, Cellular and Molecular Biology, Raven Press, New York, 1993, pp. 127–136.
H. Davson, B. V. Zlokovic, L. Rakic, and M. B. Segal. Introduction to the Blood-Brain Barrier, Macmillan Press, London, 1993, pp. 146–293.
W. H. Oldendorf. Some relationships between addiction and drug delivery to the brain. In J. Frankenheim and R. M. Brown (eds), Bioavailability of Drugs to the Brain and the Blood-Brain Barrier, NIDA Research Monographs, Washington D.C., Government Publication, 1992, pp. 13–25.
W. M. Pardridge. Plasma protein-mediated transport of steroid and thyroid hormones, Am. J. Physiol. 251: E204–E208 (1987).
W. M. Pardridge and R. J. Boado. Molecular cloning and regulation of gene expression of blood-brain barrier glucose transporter. In W. M. Pardridge (eds), The Blood-Brain Barrier, Cellular and Molecular Biology, Raven Press, New York, 1993, pp. 395–440.
B. V. Zlokovic, J. B. Mackic, L. Wang, J. G. McComb, and A. A. McDonough. Differential expression of Na,K-ATPase α and β subunit isoforms at the blood-brain barrier and the choroid plexus, J. Biol. Chem. 268: 8019–8025 (1993).
M. B. Segal and B. V. Zlokovic. Blood-Brain Barrier: Amino Acids and Peptides, Kluwer Academic Publishers, Lancaster & Boston (1990), pp. 47–123.
W. M. Pardridge. Peptide Drug Delivery to the Brain, Raven Press, New York, 1991, pp. 23–52.
E. M. Cornford, L. D. Braun, P. D. Crane, and W. H. Oldendorf. Blood-brain barrier restriction of peptides and the low uptake of enkephalins, Endocrinology 103: 1297–1303 (1978).
W. H. Oldendorf. Blood-brain barrier permeability to peptides, pitfalls in measurements, Peptides 2: 109–111 (1981).
B. V. Zlokovic, D. J. Begley, and D. G. Chain. Blood-brain permeability to di-peptides and their constituent amino acids, Brain Res. 271: 66–71 (1983).
B. V. Zlokovic, M. B. Segal, D. J. Begley, H. Davson and L. Rakic. Permeability of the blood-cerebrospinal fluid and blood-brain barriers to thyrotropin releasing hormone, Brain Res. 358: 191–199 (1985).
B. V. Zlokovic, D. J. Begley, and D. G. Chain-Eliash. Blood-brain barrier permeability to leucine-enkephalin, D-alanine2-D-leucine5-enkephalin and their N-terminal amino acid (tyrosine), Brain Res. 336: 125–132 (1985).
A. Ermisch, H. J. Ruhle, R. Landgraf, and J. Hess. Blood-brain barrier and peptides, J. Cereb. Blood Flow Metab. 5: 350–358 (1985).
R. Kannan, J. F. Kuhlenkamp, E. Jeandidier, H. Trinh, M. Ookhtens, and N. Kaplowitz. Evidence for carrier-mediated transport of glutathione across the blood-brain barrier in the rat, J. Clin. Invest. 85: 2009–2113 (1990).
R. Kannan, J. F. Kuhlenkamp, M. Ookhtens, and N. Kaplowitz. Transport of glutathione at the blood-brain barrier of the rat: inhibition by glutathione analogs and age-dependence, J. Pharmacol. Exp. Ther. 263: 964–970 (1992).
B. V. Zlokovic, J. B. Mackic, J. G. McComb, M. H. Weiss, N. Kaplowitz, and R. Kannan. Evidence for transcapillary transport of reduced glutathione in vascular perfused guinea-pig brain, Biochem. Biophys. Res. Commun. 201: 402–408 (1994).
A. J. Lastin, C. Nissan, A. V. Schaly, and D. H. Coy. Blood-brain barrier, half-time disappearance and brain distribution for labeled enkephalin and a potent analog, Brain Res. Bull. 1: 583–589 (1976).
W. M. Pardridge. Recent advances in blood-brain transport, Ann. Neurol. Pharmacol. Toxicol. 28: 25–39 (1988).
R. Kannan, J-R. Yi, Y. Li, D. Tang, B. V. Zlokovic, and N. Kaplowitz. Expression of brain capillary GSH transport in Xenopus Laevis oocytes. Soc. Neurosci. Abstr. (1995, in press)
B. V. Zlokovic, D. J. Begley, B. M. Duricic, and D. M. Mitrovic. Measurement of solute transport across the blood-brain barrier in the perfused guinea-pig brain, method and application to N-methyl-α-aminoisobutyric acid, J. Neurochem. 46: 1444–1451 (1986).
B. V. Zlokovic. In vivo approaches for studying peptide interactions at the blood-brain barrier, J. Control Release 13: 185–202 (1990).
Y. Takasato, S. I. Rapoport, and Q. R. Smith. An in situ brain perfusion technique to study cerebrovascular transport in the rat, Am. J. Physiol. 247: H484–H493 (1984).
D. Triguero, J. B. Buciak, W. M. Pardridge. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins, J. Neurochem. 54: 1882–1888 (1990).
B. V. Zlokovic, J. G. McComb, L. Perlmutter, M. H. Weiss, and H. Davson. Neuroactive peptides and amino acids at the blood-brain barrier: possible implications to drug abuse. In J. Frankenheim and R. Brown (eds), Bioavailability of Drugs to the Brain and the Blood-Brain Barrier, NIDA Research Monographs, Washington D.C., Government Publication, 1992, pp. 26–42.
A. Sam II, U. Bickel, U. Stroth, and W. M. Pardridge. Blood-brain barrier transport of neuropeptides: analysis with metabolically stable dermorphin analogue, Am. J. Physiol. 267: E124–E131 (1994).
W. M. Pardridge, D. Triguero, and J. L. Buciak. β-endorphin chimeric peptides: transport through the blood-brain barrier in vivo and cleavage of disulfide linkage by brain, Endocrinology 126: 977–984 (1990).
B. V. Zlokovic, W. A. Banks, H. ElKadi, J. Erchegyu, J. B. Mackic, J. G. McComb, and A. Kastin. Transport, uptake, and metabolism of blood-borne vasopressin by the blood-brain barrier, Brain Res. 590: 213–218 (1992).
K. R. Duffy, and W. M. Pardridge. Blood-brain barrier transcytosis of insulin in developing rabbits, Brain Res. 420: 32–38 (1987).
R. D. Broadwell, B. J. Balin, and M. Salcman. Transcytotic pathway for blood-borne protein through the blood-brain barrier, Proc. Natl Acad. Sci. 85: 632–636 (1988).
B. V. Zlokovic, M. N. Lipovac, D. J. Begley, H. Davson, and L. M. Rakic. Transport of leucine-enkephalin across the blood-brain barrier in the perfused guinea-pig brain, J. Neurochem. 49: 310–315 (1987).
B. V. Zlokovic, J. B. Mackic, B. Djuricic, and H. Davson. Kinetic analysis of leucine-enkephalin cellular uptake at the luminal side of the blood-brain barrier of an in situ perfused guinea-pig brain, J. Neurochem 53: 1333–1340 (1989).
A. J. Kastin, R. D. Olson, A. V. Schally, and D. H. Coy. CNS effects of peripherally administered brain peptides, Life Sci. 25: 401–414 (1979).
I. Bueno and J. P. Ferre. Central regulation of intestinal motility by somatostatin and cholecystokinin octapeptide, Science 216: 1427–1429 (1982).
W. A. Banks and A. J. Kastin. Aluminum alters the permeability of the blood-brain barrier to some non-peptides, Neuropharmacology 24: 407–412 (1985).
J. E. Zadina, W. A. Banks, and A. J. Kastin. Central nervous system effects of peptides. 1980–1985, a cross-listing of peptides and their central actions from the first six years of the journal Peptides, Peptides 7: 497–537 (1986).
R. G. Clark, P. M. Jones, and I. C. A. F. Robinson. Clearance of vasopressin from cerebrospinal fluid to blood in chronically cannulated Brattleboro rats, Neuroendocrinology 37: 242–247 (1983).
E. Passaro, H. Debas, W. Oldendorf, and T. Yamada. Rapid appearance of intraventricularly administered neuropeptides in the peripheral circulation, Brain Res. 241: 335–340 (1982).
B. V. Zlokovic, V. Susic, H. Davson, D. J. Begley, R. M. Jankov, D. M. Mitrovic, and M. N. Lipovac. Saturable mechanisms for delta sleep inducing peptide uptake at the blood-brain barrier of vascularly perfused guinea-pig brain, Peptides 10: 249–259 (1989).
B. V. Zlokovic, M. N. Lipovac, D. J. Begley, H. Davson and L. M. Rakic. Slow penetration of thyrotropin-releasing hormone across the blood-brain barrier of an in situ perfused guinea-pig brain, J. Neurochem. 51: 252–257 (1988).
D. J. Begley, L. K. Squires, B. V. Zlokovic, D. M. Mitrovic, C. W. Hughes, P. A. Revest, and J. Greenwood. Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin, J. Neurochem. 55: 1222–1230 (1990).
B. V. Zlokovic, J. Ghiso, J. B. Mackic, J. G. McComb, M. H. Weiss, and B. Frangione. Blood-brain barrier transport of circulating Alzheimer's amyloid β, Biochem. Biophys. Res. Commun. 197: 1034–1040 (1993).
B. V. Zlokovic, D. S. Skundric, M. B. Segal, M. N. Lipovac, J. B. Mackic, and H. Davson. A saturable mechanism for transport of immunoglobulin G across the blood-brain barrier of the guinea-pig, Exp. Neurol 107: 263–270 (1990).
B. V. Zlokovic, C. L. Martel, J. B. Mackic, E. Matsubara, T. Wisniewski, J. G. McComb, B. Frangione, and J. Ghiso. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid β, Biochem. Biophys. Res. Commun. 205: 1431–1437 (1994).
J. F. Poduslo, G. L. Curran, and C. Berg. Macromolecular permeability across the blood-nerve and blood-brain barriers, Proc. Natl. Acad. Sci. USA 91: 5705–5709 (1994).
W. A. Banks, A. J. Horvath, and E. A. Michals. Carriermediated transport of vasopressin across the blood-brain barrier of the mouse, J. Neurosci. Res. 18: 326–332 (1987).
B. V. Zlokovic, S. Hyman, J. G. McComb, M. N. Lipovac, G. Tang, and H. Davson. Kinetics of vasopressin-arginine uptake at the blood-brain barrier, Biochim. Biophys. Acta 1025: 191–198 (1990).
W. A. Banks, A. J. Kastin, and C. M. Barrera. Delivering peptides to the central nervous system: dilemmas and strategies, Pharmac. Res. 8: 1345–1350 (1991).
P. M. Friden. Receptor-mediated transport of therapeutics across the blood-brain barrier, Neurosurgery 35: 294–298 (1994).
W. M. Pardridge and L. J. Mietus. Enkephalin and blood-brain barrier: studies of binding and degradation in isolated brain microvessels, Endocrinology 109: 1138–1143 (1981).
S. I. Rapoport, W. A. Klee, K. D. Pettigrew, and K. Ohno. Entry of opioid peptides into the central nervous system, Science 207: 84–86 (1980).
N. Tsuzuki, T. Hama, T. Hibi, R. Konishi, S. Futaki, and K. Kitagawa. Adamantane as a brain-directed drug carrier for poorly absorbed drug: anti-nociceptive effects of [D-Ala2] leuenkephalin derivatives conjugated with I-adamantane moiety, Biochem. Pharmacol. 41: R5–R8 (1991).
W. A. Banks, A. J. Kastin, H. M. Sam, V. T. Cao, B. King, L. M. Maness, and A. V. Schally. Saturable efflux of the peptides RC-160 and Tyr-MIF-1 by different parts of the blood-brain barrier, Brain Res. Bull. 35: 179–182 (1994).
B. V. Zlokovic, M. B. Segal, J. G. McComb, S. Hyman, M. H. Weiss, and H. Davson. Kinetics of circulating vasopressin uptake by the choroid plexus, Am. J. Physiol. (Renal Fluid Electrolyte Physiol.) 260: F216–F224 (1991).
B. V. Zlokovic, S. Hyman, J. G. McComb, G. Tang, A. R. Rezai, and M. H. Weiss. Kinetics of vasopressin-arginine uptake by the hypothalamo-pituitary axis and pineal glands in guinea-pigs, Am. J. Physiol. (Endocrinol. Metab.) 260: E633–E640 (1991).
M. N. Lipovac, E. Barron, L. Perlmutter, M. H. Weiss, J. G. McComb, and B. V. Zlokovic. Chronic nicotine treatment increases blood-brain transport and capillary sequestration of vasopressin in nicotine-treated guinea-pigs, Soc. Neurosci. Abstr. 18: 1492 (1992).
J. F. Wilson. Low permeability of the blood-brain barrier to nanomolar concentrations of immunoreactive alphamelanotropin, Psychopharmacology 96: 262–266 (1988).
K. L. Audus, P. J. Chickhale, D. W. Miller, S. E. Thompson, and R. T. Borchardt. Brain uptake of drugs: the influence of chemical and biological factors, Adv. Drug Res. 23: 1–64 (1992).
B. V. Zlokovic, M. B. Segal, H. Davson, and R. M. Jankov. Passage of delta sleep-inducing peptide (DSIP) across the blood-cerebrospinal fluid barrier, Peptides 9: 533–538 (1988).
B. V. Zlokovic, M. B. Segal, H. Davson, and D. M. Mitrovic. Unidirectional uptake of enkephalins at the blood-tissue interface of the blood-cerebrospinal fluid barrier: a saturable mechanism, Regul. Peptides 20: 33–44 (1988).
W. M. Pardridge, D. Triguero, J. Yang, and P. A. Cancilla. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier, J. Pharmacol. Exp. Ther. 253: 884–891 (1990).
W. A. Banks, A. J. Kastin, V. Akerstrom, and J. B. Jaspan. Radioactively iodinated cyclo(His-Pro) crosses the blood-brain barrier and reverses ethanol-induced narcosis, Am. J. Physiol. (Endocrinol. Metab.) 264: E723–E729 (1993).
Y.-S. Kang and W. M. Pardridge. Use of neutral-avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate, J. Pharmacol. Exp. Ther. 269: 344–350 (1994).
P. M. Friden, L. R. Walus, P. Watson, S. R. Doctrow, J. W. Kozarich, C. Backman, H. Bergman, B. Hoffer, F. Bloom, and A.-C. Granholm. Blood-brain barrier penetration and in vivo activity of an NGF conjugate, Science 259: 373–377 (1993).
U. Bickel, T. Yoshikawa, E. M. Landaw, K. F. Faull, and W. M. Pardridge. Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery, Proc. Natl. Acad. Sci. 90: 2618–2622 (1993).
J.-R. Yi, S. Lu, J. Fernandez-Checa, and N. Kaplowitz. Expression cloning of a rat hepatic reduced glutathione transporter with canalicular characteristics, J. Clin. Invest. 93: 1841–1845 (1994).
J. Ghiso, T. Wisniewski, and B. Frangione. Unifying features of systemic and cerebral amyloidosis. Mol. Neurobiol. 8: 49–64 (1994).
B. V. Zlokovic, C. L. Martel, J. B. Mackic, E. Matsubara, T. Wisniewski, J. G. McComb, B. Frangione, and J. Ghiso. Blood-brain barrier transport and cerebral capillary sequestration of Alzheimer's amyloid ß: modifications by apolipoproteins J, E3 and E4, Cereb. Vasc. Biol. Conference, Paris, 10–12 July (1995).
A. Koudinov, E. Matsubara, B. Frangione, and J. Ghiso. The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma, Biochem. Biophys. Res. Commun. 205: 1164–1171 (1994).
E. Matsubara, B. Frangione, and J. Ghiso. Characterization of apolipoprotein J-Alzheimer's amyloid beta interaction, J. Biol. Chem. 270: 7563–7567 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zlokovic, B.V. Cerebrovascular Permeability to Peptides: Manipulations of Transport Systems at the Blood-Brain Barrier. Pharm Res 12, 1395–1406 (1995). https://doi.org/10.1023/A:1016254514167
Issue Date:
DOI: https://doi.org/10.1023/A:1016254514167